Literature DB >> 6491947

Determination of ethoxzolamide in the iris/ciliary body of the rabbit eye by high-performance liquid chromatography: comparison of tissue levels following intravenous and topical administrations.

M G Eller, R D Schoenwald.   

Abstract

A specific high-performance liquid chromatographic method is described for ethoxzolamide following the extraction of the material from iris/ciliary body eye tissue in rabbits. The steps consist of base extraction and protein and enzyme deactivation, followed by acid treatment, extraction into ethyl acetate, evaporation, and solubilization with a 50% aqueous methanol solution. The samples were chromatographed on a reverse-phase phenyl column with a mobile phase consisting of 50% methanol in 1% acetic acid. The recovery was 74.3% over a 10-fold range of tissue concentrations. The sensitivity was 0.03 microgram/mL, and the response was linear over the concentration range (0.03-0.5 microgram/mL) used in the study. Intravenous (2.0- and 6.0-mg/kg) and topical (1% suspension) doses of ethoxzolamide were administered to rabbits. Iris/ciliary body tissues were excised 45 min after drug administration. The tissue levels after a dose of 6 mg/kg were statistically greater than the levels obtained after a dose of 2 mg/kg. The smaller intravenous dose represented the lowest dose for which a reduction in intraocular pressure could be measured. An initial transitory drop in intraocular pressure was detected for the topical dose. Iris/ciliary body levels in the treated eye could be detected for the 2-mg/kg iv and topical doses.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6491947     DOI: 10.1002/jps.2600730918

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  The effect of azone on ocular levobunolol absorption: calculating the area under the curve and its standard error using tissue sampling compartments.

Authors:  D D Tang-Liu; P J Burke
Journal:  Pharm Res       Date:  1988-04       Impact factor: 4.200

2.  The Carbonic Anhydrase Inhibitor Ethoxzolamide Inhibits the Mycobacterium tuberculosis PhoPR Regulon and Esx-1 Secretion and Attenuates Virulence.

Authors:  Benjamin K Johnson; Christopher J Colvin; David B Needle; Felix Mba Medie; Patricia A DiGiuseppe Champion; Robert B Abramovitch
Journal:  Antimicrob Agents Chemother       Date:  2015-05-18       Impact factor: 5.191

3.  Development and validation of an UPLC-MS/MS method for the quantification of ethoxzolamide in blood, brain tissue, and bioequivalent buffers: applications to absorption, brain distribution, and pharmacokinetic studies.

Authors:  Song Gao; Jing Zhao; Taijun Yin; Yong Ma; Beibei Xu; Anthony N Moore; Pramod K Dash; Ming Hu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-02-07       Impact factor: 3.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.